AI增强常规CT用于机会性骨质疏松筛查与风险评估
本综述评估AI利用常规CT进行机会性骨质疏松病例发现与风险评估,强调回顾性诊断性能与安全临床实施之间的边界。自动椎体分割和CT骨密度估算可减少人工工作量,但参考标准、解剖目标、采集重建、对比剂状态、校准方法和验证设计差异大导致汇总估计异质,无法给出通用CT阈值或最低探测器排数要求。AI应作为经过验证的分诊工具,而非独立诊断替代临床评估和指征性DXA/QCT。
要点
- AI自动椎体分割和CT骨密度估算可减少人工工作量,但回顾性高判别力不等于临床可安全实施。
- 研究间参考标准、采集重建、对比剂、校准和验证设计差异大,无法确定通用CT阈值或探测器排数要求。
- AI应作为分诊工具,需外部验证并建立从AI警报至确认检查和治疗评估的明确路径。
核心结论
- AI增强常规CT有望用于机会性骨质疏松病例发现和风险评估,但当前证据不支持将其作为独立诊断工具,应作为经过验证的分诊工具整合入放射学工作流程。
研究设计与样本
- 本文为综述,评估人工智能利用常规CT进行机会性骨质疏松病例发现和风险评估,未报告系统检索范围、纳入文献数量或样本量。
关键影像表现/征象
- 自动椎体分割和CT衍生骨密度估算可减少人工工作量,已发表的诊断研究在选定队列中报告高判别力。
诊断标准与关键数值
- 由于参考标准、解剖目标、CT采集、重建、对比剂状态、校准方法、患病率和验证设计差异显著,无法确定通用CT阈值或通用最低探测器排数要求。
临床应用与阅片要点
- AI部署需包括明确的CT协议资格检查、预设椎体感兴趣区和排除标准、协议和对比剂感知的定量、适用的扫描仪特异性质量保证和校准监测、代表性人群外部验证,以及从AI警报至确认检查和治疗评估的明确路径。
- 探测器排数配置应结合更广泛的采集和重建参数考虑,而非单独作为标准。
局限性
- 已发表诊断研究的汇总估计异质性大,且证据多为回顾性性能,缺乏下游检查、治疗、骨折、工作量、公平性和成本结局的前瞻性评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Osteoporosis-related fractures create a large and often preventable burden, yet many individuals undergoing CT for unrelated care do not receive skeletal assessment. This review evaluates artificial intelligence (AI)-enabled use of routine CT for opportunistic case-finding and risk assessment, with emphasis on the boundary between promising retrospective performance and safe clinical implementation. Automated vertebral segmentation and CT-derived bone-density estimation can reduce manual workload, and published diagnostic studies report high discrimination in selected cohorts. However, pooled estimates are heterogeneous because the reference standard, anatomical target, CT acquisition, reconstruction, contrast status, calibration method, prevalence, and validation design differ substantially across studies. These differences preclude a universal CT threshold or a universal minimum detector-row requirement; detector-row configuration should be considered together with the broader acquisition and reconstruction parameters. For implementation, AI should be deployed as a validated triage tool-not as a stand-alone diagnostic replacement for clinical assessment and indicated DXA/QCT. A credible pathway requires a defined CT-protocol eligibility check; pre-specified vertebral region of interest and exclusions; protocol- and contrast-aware quantification; scanner-specific quality assurance and calibration monitoring where applicable; external validation in representative populations; and an explicit route from an AI alert to confirmatory testing and treatment evaluation. AI may also enable concurrent vertebral-fracture and body-composition assessment, but clinical utility must be shown through downstream testing, treatment, fracture, workload, equity, and cost outcomes. The near-term priority is therefore not higher retrospective diagnostic performance alone, but reproducible, transparent, and prospectively evaluated integration into radiology workflows.
引用
- Guo M, Xu R, Miao Z, et al. AI-enhanced routine CT for opportunistic osteoporosis screening and risk assessment. Skeletal Radiol. 2026. PMID: 42881278. doi:10.1007/s00256-026-05403-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。